Risk factors for necrotic cholecystitis during the COVID-19 pandemic: the ChoCO-WSES prospective collaborative study's experience.
COVID-19
ChoCO-W
Cholecystitis
SARS-CoV-2
WSES
management
Journal
Turkish journal of surgery
ISSN: 2564-6850
Titre abrégé: Turk J Surg
Pays: Turkey
ID NLM: 101704837
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
11
09
2021
accepted:
08
11
2021
entrez:
9
6
2022
pubmed:
10
6
2022
medline:
10
6
2022
Statut:
epublish
Résumé
During the COVID-19 pandemic, several studies have reported a decrease in in the admission surgical patients and emergency surgical procedures, and an increase in more severe septic surgical diseases, such as necrotic cholecystitis. It was probably due to to a critical delay in time-to- diagnosis and time-to-intervention resulting to limited access to the operating theatres as well as intensive care units. Early laparoscopic cholecystec- tomy is the standard of care for acute cholecystitis. Moreover early data from COVID-19 pandemic reported an increase in the incidence of necrotic cholecystitis among COVID-19 patients. The ChoCO-W prospective observational collaborative study was conceived to investigate the incidence and management of acute cholecystitis under the COVID-19 pandemic. The present research protocol was. conceived and designed as a prospective observational international collaborative study focusing on the management of patients with to the diagnosis of acute cholecystitis under the COVID-19 pandemic. The study obtained the approval of the local Ethics Committee (Nimes, France) and meet and conform to the standards outlined in the Declaration of Helsinki. Eligible patients will be prospectively enrolled in the recruitment period and data entered in an online case report form. The ChoCO-W study will be the largest prospective study carried out during the first period of the COVID-19 pandemic with the aim to inves- tigate the management of patients with acute cholecystitis, in the lack of studies focusing on COVID-19 positive patients. The ChoCO-W study is conceived to be the largest prospective study to assess the management of patients presenting with acute chol- ecystitis during the COVID-19 pandemic and risk factors correlated with necrotic cholecystitis to improve the management of high-risk patients.
Identifiants
pubmed: 35677497
doi: 10.47717/turkjsurg.2021.5507
pmc: PMC9130934
doi:
Types de publication
Journal Article
Langues
eng
Pagination
387-393Informations de copyright
Copyright © 2021, Turkish Surgical Society.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors have no conflicts of interest to declare.
Références
Am J Surg. 2015 Oct;210(4):730-3
pubmed: 26186803
Eur J Trauma Emerg Surg. 2021 Jun;47(3):683-692
pubmed: 33742223
BMC Surg. 2021 Apr 6;21(1):180
pubmed: 33823831
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):55-72
pubmed: 29045062
Updates Surg. 2020 Sep;72(3):917-919
pubmed: 32458339
World J Emerg Surg. 2021 Mar 22;16(1):14
pubmed: 33752721
Ulus Travma Acil Cerrahi Derg. 2020 Dec;27(1):34-42
pubmed: 33394479
Br Med J. 1964 Jul 18;2(5402):177
pubmed: 14150898
World J Emerg Surg. 2020 Nov 5;15(1):61
pubmed: 33153472
Ann Med Surg (Lond). 2020 Dec;60:434-437
pubmed: 33224493
World J Emerg Surg. 2020 Jun 8;15(1):38
pubmed: 32513287
Ann Med Surg (Lond). 2020 Oct;58:73-75
pubmed: 32895611
Ann Hepatobiliary Pancreat Surg. 2019 Feb;23(1):34-40
pubmed: 30863805
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41-54
pubmed: 29032636
Ann R Coll Surg Engl. 2020 May;102(5):323-332
pubmed: 32352836
Ulus Travma Acil Cerrahi Derg. 2020 Dec;27(1):89-94
pubmed: 33394477
Int Surg. 2015 Feb;100(2):254-60
pubmed: 25692427
World J Emerg Surg. 2020 Jul 2;15(1):43
pubmed: 32615987